Healthcare provider profile · identity verified

Ramon A Cintron, MD

Family Practice · DALLAS, TX · NPI 1912981655

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	978	326
Levothyroxine Sodium	Levothyroxine Sodium	549	152
Metformin Hcl	Metformin Hcl	444	140
Lisinopril	Lisinopril	430	152
Amlodipine Besylate	Amlodipine Besylate	400	137
Rosuvastatin Calcium	Rosuvastatin Calcium	326	102
Losartan Potassium	Losartan Potassium	320	106
Metoprolol Succinate	Metoprolol Succinate	281	92
Pantoprazole Sodium	Pantoprazole Sodium	279	96
Gabapentin	Gabapentin	233	92
Tamsulosin Hcl	Tamsulosin Hcl	227	76
Montelukast Sodium	Montelukast Sodium	217	79
Alendronate Sodium	Alendronate Sodium	215	71
Hydrochlorothiazide	Hydrochlorothiazide	192	63
Trazodone Hcl	Trazodone Hcl	188	64
Omeprazole	Omeprazole	183	69
Vitamin D2	Ergocalciferol (Vitamin D2)	152	60
Furosemide	Furosemide	149	55
Fluticasone Propionate	Fluticasone Propionate	147	59
Albuterol Sulfate Hfa	Albuterol Sulfate	126	57
Carvedilol	Carvedilol	123	45
Glipizide	Glipizide	119	38
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	111	39
Tramadol Hcl	Tramadol Hcl	101	31
Famotidine	Famotidine	100	33
Celecoxib	Celecoxib	99	36
Escitalopram Oxalate	Escitalopram Oxalate	98	34
Pioglitazone Hcl	Pioglitazone Hcl	97	33
Allopurinol	Allopurinol	94	28
Glimepiride	Glimepiride	94	33
Ezetimibe	Ezetimibe	88	29
Pravastatin Sodium	Pravastatin Sodium	88	32
Clopidogrel	Clopidogrel Bisulfate	87	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	25
Mounjaro	Tirzepatide	80	14
Tizanidine Hcl	Tizanidine Hcl	80	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	24
Simvastatin	Simvastatin	75	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	32
Hydralazine Hcl	Hydralazine Hcl	74	18
Meloxicam	Meloxicam	72	28
Ozempic	Semaglutide	70	16
Metoprolol Tartrate	Metoprolol Tartrate	69	28
Telmisartan	Telmisartan	69	20
Triamcinolone Acetonide	Triamcinolone Acetonide	67	32
Trulicity	Dulaglutide	67	15
Prednisone	Prednisone	63	54
Januvia	Sitagliptin Phosphate	61	23
Duloxetine Hcl	Duloxetine Hcl	59	25
Valsartan	Valsartan	59	19
Potassium Chloride	Potassium Chloride	58	18
Sertraline Hcl	Sertraline Hcl	56	24
Finasteride	Finasteride	55	20
Mirtazapine	Mirtazapine	52	18
Doxazosin Mesylate	Doxazosin Mesylate	51	16
Donepezil Hcl	Donepezil Hcl	50	20
Synthroid	Levothyroxine Sodium	49	15
Citalopram Hbr	Citalopram Hydrobromide	48	16
Zolpidem Tartrate	Zolpidem Tartrate	48	12
Metformin Hcl Er	Metformin Hcl	47	17
Baclofen	Baclofen	46	11
Nystatin	Nystatin	46	28
Naproxen	Naproxen	45	11
Azithromycin	Azithromycin	44	41
Alprazolam	Alprazolam	42	15
Eliquis	Apixaban	42	18
Jardiance	Empagliflozin	42	15
Rybelsus	Semaglutide	42	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	38
Esomeprazole Magnesium	Esomeprazole Magnesium	41	16
Olmesartan Medoxomil	Olmesartan Medoxomil	40	14
Clonazepam	Clonazepam	38	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	38	11
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Glipizide Er	Glipizide	36	suppressed
Atenolol	Atenolol	35	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	27
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Spironolactone	Spironolactone	32	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	11
Meclizine Hcl	Meclizine Hcl	30	16
Venlafaxine Hcl Er	Venlafaxine Hcl	30	11
Cephalexin	Cephalexin	29	26
Myrbetriq	Mirabegron	29	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	29	11
Buspirone Hcl	Buspirone Hcl	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Primidone	Primidone	27	suppressed
Colestipol Hcl	Colestipol Hcl	26	12
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Estradiol	Estradiol	21	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Torsemide	Torsemide	20	suppressed
Memantine Hcl Er	Memantine Hcl	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	17	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Fenofibrate	Fenofibrate	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Lubiprostone	Lubiprostone	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Dutasteride	Dutasteride	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Risedronate Sodium	Risedronate Sodium	14	suppressed
Silodosin	Silodosin	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Humira(Cf) Pen	Adalimumab	13	suppressed
Ramipril	Ramipril	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Colchicine	Colchicine	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lactulose	Lactulose	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error